Skip Navigation
News & Information Services
 
 
 
 
 
Print This Page
Share this page: More
 

Statement regarding PolyHeme

Johns Hopkins Medicine
Media Relations and Public Affairs
CONTACT:  Joann Rodgers
PHONE:  410-955-8659
E-MAIL:  jrodgers@jhmi.edu
March 23, 2006

Statement regarding PolyHeme
 
Contrary to a statement made as part of a press release by Northfield Laboratories of Evanston, Ill, on Feb. 22, 2006, a Johns Hopkins Medicine faculty member, Edward Norris, M.D., is not presenting information about a clinical trial of the company’s blood substitute PolyHeme at the annual meeting of the Network for the Advancement of Transfusion Alternatives (NATA) in April 2006; was not given access to full study results from Northfield; and does not and cannot substantiate Northfield’s claim that PolyHeme was unlikely to have been the cause of 10 heart attacks and 2 deaths in patients receiving the blood substitute as part of a clinical trial that ended in 2000.

Johns Hopkins Medicine has asked Northfield to retract its February 22 release and to reissue a corrected version.

The company’s release challenged a Wall Street Journal article that questions the Acute Normovolemic Hemodilution (ANH) multi-center clinical trial, begun in the late 1990s.

Dr. Norris was among those who participated in the clinical trial.

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer